Testing effectiveness (Phase 2)Study completedNCT03562377
What this trial is testing
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Who this might be right for
Atopic Dermatitis
LEO Pharma 215